Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Managed Care Experts

Articles with lock require a subscription to GLG News | Request a free trial
Frederic GoldsteinFebruary 29, 2008
Can Technology Slow the Growth in Health Care Costs
Analysis of: As Healthcare Spending is Predicted to Exceed 4 Trillion in Less Than 10 Years, Technology will be Called upon to Stem the Tide | biz.yahoo.com
Author: Frederic Goldstein, President and Chief Operating Officer, U.S. Preventive Medicine, Inc.
Technology is proposed as a means to control health care costs through making the system more efficient.  While a more efficient system will certainly be helpful, our current population needs a change in behavior in a societal way if we truly hope to bend the trend.
Frederic GoldsteinFebruary 29, 2008
Changing the Society is the Way of the Future to Bend the Medical Trend
Analysis of: New York using "green carts" in latest obesity fight | news.yahoo.com
Author: Frederic Goldstein, President and Chief Operating Officer, U.S. Preventive Medicine, Inc.
We are beginning to see the changes required to create a movement around the idea of prevention. Companies that can focus on this space and produce results will be the future of health care.
February 25, 2008
Be Careful What You Wish For
Analysis of: Forget India; Call Centers Boom in Caribbean | abcnews.go.com
Author: GLG Expert Contributor
The Caribbean Basin offers a variety of benefits and opportunities for business, but it is far from the panacea for outsourcing. Only those who are first to act may benefit, and even then not without some problems.
February 19, 2008
Chinese Heparin Debacle May Cause World Wide Shortage for Dialysis Providers
Analysis of: China Plant Played Role | online.wsj.com
Author: Joe Atkins, Chief Executive Officer, Medical Concepts & Innovations
Although patient deaths are of grave concern, the impact of a heparin shortage stand to put around 400,000 US dialysis patients at risk.  Heparin is the "oil of hemodialysis" and without it, hemodialysis would come to a standstill. There are alternatives available, such as Andiomax and Lovenox,...
Frederic GoldsteinFebruary 14, 2008
Healthways Fires Back Over CMS Release of Phase I Results
Analysis of: Healthways Questions CMS' Conclusions with Regard to Company's MHS Phase I Pilot | biz.yahoo.com
Author: Frederic Goldstein, President and Chief Operating Officer, U.S. Preventive Medicine, Inc.
Healthways has apparently decided that it is in their best interest to fight back against CMS over the recently released CMS report stating that vendors in Phase I of the Medicare Health Support Projects did not meet outcome or cost results. This may prove short sighted, and is certainly no way to make...
February 11, 2008
Offshoring clinical trials...damned if you do, damned if you don't!
Analysis of: New lease on life? The ethics of offshoring clinical trials | www.ft.com
Author: GLG Expert Contributor
Pharmaceutical companies have an option. They can continue to endure increaingly higher costs, rigid regulatory pressures, and hostile special interests, or they can explore new alternatives that will allow them meet their mission and realize a reasonable retrun on investment. Which would you...
February 11, 2008
Fosamax generic...
Analysis of: Teva wins FDA OK to sell generic Fosamax | www.reuters.com
Author: David Zimmerman, President/Owner, Doctors of Pharmacy, Inc.
It is important to understand the generic implications when it comes to drug product olacement on the formulary.
February 11, 2008
Zyprexa safety
Analysis of: FDA Advisory Committee Supports Efficacy and Safety of Zyprexa | www.fiercebiotech.com
Author: David Zimmerman, President/Owner, Doctors of Pharmacy, Inc.
This article is informative because it draws conclusions about Zyprexa.
February 6, 2008
Is Insurance the Solution? Depends on What is the Problem.
Analysis of: Blue Cross proposes fix for uninsured Americans | news.yahoo.com
Author: GLG Expert Contributor
1. Insurance facilitates payment. It does nothing on its own to resolve issues of access, quality, or unmet health care needs. 2. Is the right care readily available with only cost being the obstacle for some of the population, or is there a distribution problem? 3. Would increased assistance to...
Richard BalandFebruary 6, 2008
Walk in Clinic business may not be as easy as it appears.
Analysis of: Operator of Walk-In Clinics Shuts 23 Located in Wal-Mart Stores | www.nytimes.com
Author: Richard Baland, Partner, B2B CFO
Yes, WalMart has a large pool of patients. And there are competitive advantages with regard to the convenience of a pharmacy and over the counter remedies. However, having patients is only one piece of the puzzle. The business of medicine is more complex than merely having patients or customers.

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next71 to 80 of 288

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-02T01:45:17.000